| 摘要 |
<P>PROBLEM TO BE SOLVED: To provide a therapeutic agent that suppresses an inflammation for a long period of time without producing a serious side effect in the pharmacotherapy for a patient with an inflammatory bowel disease. <P>SOLUTION: This antihuman TNF-α antibody activity decrease inhibitor, characterized by containing a protein source and/or carbohydrate source, is used in a repeated administration of the anti-TNF-α antibody for the treatment of the inflammatory bowel disease. <P>COPYRIGHT: (C)2012,JPO&INPIT |
